Eli Lilly & Co.

LLY · Pharmaceutical Preparations · $1.1T
Cooling off
LLY
$1,152.93
▲ +0.04%
09/18 O 1150.00 H 1157.60 L 1140.27 C 1152.93 ▲ +0.04%
Vol 4.5M RS 75
RS rating75
Now vs pivot (%)−7.72%
Tightening (ATR ratio)0.90×
Volume dry-up0.80×
Up/down volume, net-0.02
From 52-week high11%
played out
Cooling off
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

The read

The base has run 6.2 weeks and fell 11% from its ceiling at its deepest. The pivot is $1249.45, and the stock closed 7.7% below it. Its relative strength rating is 75.

Also on
Peers
Catalyst roadmap
  1. Earningstentativein 41d
    Quarterly earnings
    Oct 29, 2026
  2. EarningstentativeAAPL · industryin 41d
    AAPL reports
    Oct 29, 2026
Flagged by the market sweep

Nothing flagged for this company on the last market sweep.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Eli Lilly & Co. (LLY) — The Tape